Pro Share Advisors LLC Relmada Therapeutics, Inc. Transaction History

Pro Share Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	BUY	$18.3 - $37.02 $101,327 - $204,979	5,537 New	5,537 $205,000
Q2 2022 Aug 01, 2022	SELL	$16.5 - $30.34 $124,179 - $228,338	-7,526 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$16.72 - $26.99 $125,834 - $203,126	7,526 New	7,526 $203,000
Q3 2021 Nov 12, 2021	SELL	$21.86 - $34.77 $151,052 - $240,260	-6,910 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$29.55 - $39.15 $22,014 - $29,166	745 Added 12.08%	6,910 $221,000
Q1 2021 May 14, 2021	BUY	$31.52 - $39.28 $194,320 - $242,161	6,165 New	6,165 $217,000

12.3M

229K

138K

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $79M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.